Switch to:
More From Other Websites
Valeant and Gilead: Beaten Down Bargains or Truly Terrible? May 23 2017
Amgen's Woes: It Could Always Be Worse! May 22 2017
Cramer's lightning round: I've got a message for the struggling Gilead Sciences May 19 2017
5 Reasons Big Biotech Could Gain 25%-30% May 19 2017
Why Stay Bullish On Gilead May 19 2017
Revisiting Bristol-Myers Squibb’s Virology in 1Q17 May 19 2017
Top 5 Biotech Stocks for 2017 May 19 2017
A Doomed Trump Presidency Would Be a Terrifying Development for Pharmaceutical Stocks May 18 2017
3 Dividend Stocks You Haven't Thought Of May 17 2017
3 Best Dividend Stocks in Biotech May 16 2017
Gilead's last chronic HIV drug — and what it plans to do now May 15 2017
Blog Coverage: Ardelyx Reports Successful Trial Results for Treatment of Patients with Irritable... May 15 2017
Better Buy: Gilead Sciences, Inc. vs. Amgen Inc. May 14 2017
Johnson & Johnson Analyst Day May 12 2017
3 Top Biotech Stocks For May May 11 2017
Major Biotech Short Interest Remains Mixed May 10 2017
Why Gilead Sciences Stock Lagged Behind Other Biotechs in April May 10 2017
Here's Why Diplomat Pharmacy Inc. Is Rising Today May 09 2017
I Still Can't Believe Gilead Sciences, Inc. Spent $14.8 Billion on Shareholder Rewards May 09 2017
3 Stocks That Generate Tons of Cash May 09 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK